Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson’s disease therapy - Concepedia

Concepedia

Publication | Open Access

Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson’s disease therapy

DOI Full Paper Access

51

Citations

21

References

2020

Year

Fernanda Rodríguez‐Enríquez, María Carmen Costas-Lago, Pedro Besada, Miguel Alonso-Pena, Iria Torres-Terán, Dolores Viña, José A. Fontenla, Mattia Sturlese, Stefano Moro, Elías Quezada,

Bioorganic Chemistry

Molecular PharmacologyMedicinePsychotropic MedicationNeuropharmacologySelective Mao-b InhibitorsPharmacotherapyNovel Coumarin-pyridazine HybridsPharmacologyPharmaceutical ChemistryDrug Discovery

References

	Year	Citations

Page 1

Page 1